The data from this research indicate that the expression of TMEFF2 is associated with the development and progression, as well as the prognosis, of endometrial cancer, and may also assist in identifying therapeutic targets for the endometrium [46]. The gene discussed is TMEFF2; the disease is endometrial cancer.